Literature DB >> 2210741

Cystic fibrosis in Greece: typing with DNA probes and identification of the common molecular defect.

A Balassopoulou1, D Loukopoulos, P Kollia, M Devoto, G Adam, S Arvanitakis, H Hadjisevastou.   

Abstract

The relative frequency of the delta F508 mutation in the Greek population is 54.1%; this is similar to that reported in other Southern European populations and contrasts with the considerably higher frequencies encountered in Northern Europe and North America. The low frequency is in agreement with the linkage disequilibrium already reported between cystic fibrosis and haplotype B in this country. In contrast to the common association of pancreatic insufficiency with the homozygous delta F508 genotype, the present study revealed two homozygous children with no evidence of pancreatic failure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210741     DOI: 10.1007/bf02428270

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  4 in total

1.  Mutation analysis of ten exons of the CFTR gene in Greek cystic fibrosis patients: characterization of 74.5% of CF alleles including one novel mutation.

Authors:  E Kanavakis; M Tzetis; T Antoniadi; J Traeger-Synodinos; S Doudounakis; G Adam; N Matsaniotis; C Kattamis
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

2.  Cystic fibrosis mutations delta F508 and G542X in Jewish patients.

Authors:  I Lerer; M Sagi; G R Cutting; D Abeliovich
Journal:  J Med Genet       Date:  1992-02       Impact factor: 6.318

3.  Novel cystic fibrosis mutation associated with mild disease in Cypriot patients.

Authors:  K Boteva; E Papageorgiou; C Georgiou; M Angastiniotis; L T Middleton; C D Constantinou-Deltas
Journal:  Hum Genet       Date:  1994-05       Impact factor: 4.132

4.  The Incidence of Cystic Fibrosis in the Central Region of Anatolia in Turkey Between 2015 and 2016

Authors:  Melih Hangül; Sevgi Pekcan; Mehmet Köse; Deniz Acıcan; Tuba Esra Şahlar; Murat Erdoğan; Mustafa Kendirci; Deniz Güney; Hasan Öznavruz; Osman Demir; Ömür Ercan; Fatma Göçlü
Journal:  Balkan Med J       Date:  2018-12-28       Impact factor: 2.021

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.